Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 13, 2022
The Role of Immunotherapy in the Management of Soft Tissue Sarcomas: Current Landscape and Future Outlook
Lauren B Banks, Sandra P D'Angelo
American Journal of Clinical Dermatology
|
February 7, 2020
When is it OK to Stop Anti-Programmed Death 1 Receptor (PD-1) Therapy in Metastatic Melanoma?
Lauren B Banks, Ryan J Sullivan
JBJS Reviews
|
December 20, 2023
Team Approach: Extremity Soft Tissue Sarcoma
Carol D Morris, Lauren B Banks, Valerie A Fitzhugh, et al.
Biorxiv : the Preprint Server for Biology
|
June 25, 2024
Akt2 deficiency impairs Th17 differentiation, augments Th2 differentiation, and alters the peripheral response to immunization
Lauren B Banks, Tammarah Sklarz, Mercy Gohil, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 19, 2017
The Loss of TET2 Promotes CD8<sup>+</sup> T Cell Memory Differentiation
Shannon A Carty, Mercy Gohil, Lauren B Banks, et al.
Cancer Medicine
|
June 21, 2026
Concomitant Medication Effects on Immunotherapy Outcomes in Sarcoma: A Pooled Post Hoc Analysis of Seven Phase II Trials
Adel Shahnam, Kristen DiConza, Simran Jasnani, et al.
Nature Immunology
|
May 7, 2013
Natural and inducible TH17 cells are regulated differently by Akt and mTOR pathways
Jiyeon S Kim, Tammarah Sklarz, Lauren B Banks, et al.
Journal for Immunotherapy of Cancer
|
September 5, 2025
High transposable element expression in sarcomas is associated with increased immune infiltrates and improved outcomes including after immunotherapy
Benjamin A Nacev, Martina Bradic, Hyung Jun Woo, et al.
Nature Medicine
|
April 28, 2022
Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CA
Smita S Chandran, Jiaqi Ma, Martin G Klatt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 15, 2024
Histology-Specific Clinical Trial of Lenvatinib and Pembrolizumab in Patients with Sarcoma
Sujana Movva, Kenneth Seier, Viswatej Avutu, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 13, 2022
The Role of Immunotherapy in the Management of Soft Tissue Sarcomas: Current Landscape and Future Outlook
Lauren B Banks, Sandra P D'Angelo
American Journal of Clinical Dermatology
|
February 7, 2020
When is it OK to Stop Anti-Programmed Death 1 Receptor (PD-1) Therapy in Metastatic Melanoma?
Lauren B Banks, Ryan J Sullivan
JBJS Reviews
|
December 20, 2023
Team Approach: Extremity Soft Tissue Sarcoma
Carol D Morris, Lauren B Banks, Valerie A Fitzhugh, et al.
Biorxiv : the Preprint Server for Biology
|
June 25, 2024
Akt2 deficiency impairs Th17 differentiation, augments Th2 differentiation, and alters the peripheral response to immunization
Lauren B Banks, Tammarah Sklarz, Mercy Gohil, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 19, 2017
The Loss of TET2 Promotes CD8<sup>+</sup> T Cell Memory Differentiation
Shannon A Carty, Mercy Gohil, Lauren B Banks, et al.
Cancer Medicine
|
June 21, 2026
Concomitant Medication Effects on Immunotherapy Outcomes in Sarcoma: A Pooled Post Hoc Analysis of Seven Phase II Trials
Adel Shahnam, Kristen DiConza, Simran Jasnani, et al.
Nature Immunology
|
May 7, 2013
Natural and inducible TH17 cells are regulated differently by Akt and mTOR pathways
Jiyeon S Kim, Tammarah Sklarz, Lauren B Banks, et al.
Journal for Immunotherapy of Cancer
|
September 5, 2025
High transposable element expression in sarcomas is associated with increased immune infiltrates and improved outcomes including after immunotherapy
Benjamin A Nacev, Martina Bradic, Hyung Jun Woo, et al.
Nature Medicine
|
April 28, 2022
Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CA
Smita S Chandran, Jiaqi Ma, Martin G Klatt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 15, 2024
Histology-Specific Clinical Trial of Lenvatinib and Pembrolizumab in Patients with Sarcoma
Sujana Movva, Kenneth Seier, Viswatej Avutu, et al.
Page
of 2